Channels - Efficacy and Safety of Insulin Efsitora Versus Degludec in Adults with Type 2 Diabetes Who Are Insulin-Naïve: Japan Subgroup Analysis of QWINT-2 :: FRELIP Discovery

Similar Items: Efficacy and Safety of Insulin Efsitora Versus Degludec in Adults with Type 2 Diabetes Who Are Insulin-Naïve: Japan Subgroup Analysis of QWINT-2

Quick Look
Sestrin-2: a new biomarker for type 2 Diabetes Mellitus and Insulin resistance
Quick Look
Cost‐effectiveness analysis comparing real‐time continuous glucose monitoring with self‐monitoring of blood glucose for patients with type 2 diabetes treated with insulin in Japan
Quick Look
Pen Needle Reuse in People with Diabetes Who Inject Insulin: A Narrative Review
Quick Look
Role of the UHRF1–KLHL6–CORO2B axis in obesity‐related insulin resistance
Quick Look
Optimizing Type 2 Diabetes Management in Iraq: Expert Consensus on Initiation and Intensification of Insulin-Based Treatment Options
Quick Look
Insulin‐reducing effect of adding imeglimin to ongoing dipeptidyl peptidase‐4 inhibitor therapy with multiple daily insulin injections (INSPIRE study)
Quick Look
Correspondence: Effects of short‐term tofogliflozin treatment on insulin secretory capacity in type 2 diabetes: Insights and future directions
Quick Look
Basal Insulin Adherence in Patients with Type 2 Diabetes Mellitus in Routine Clinical Practice in Spain: Clinical and Economic Impact
Quick Look
Correction to “Effects of short‐term tofogliflozin treatment on the insulin secretory capacity of people with type 2 diabetes: A randomized controlled trial, the TOP‐2ELM study”
Quick Look
Associations of finerenone with reduced insulin resistance in patients with type 2 diabetes and chronic kidney disease: A real‐world observational study
Quick Look
Real-time continuous glucose monitoring in adults with type 2 diabetes managed with non-intensive insulin regimens: impact on glycemia and self-management
Quick Look
Correction: Comparative Safety of SGLT2 Versus DPP4 Inhibitors in Patients with Type 2 Diabetes: A Meta‑Analysis of Randomized Controlled Trials
Quick Look
Real-World Performance of the MiniMed 780G Advanced Hybrid Closed Loop Automated Insulin Delivery System in Greece
Quick Look
Comparative efficacy and safety of three fixed‐ratio combination products in type 2 diabetes: A network meta‐analysis
Quick Look
Five‐year follow‐up of incretin‐based therapy in a patient with KCNJ11‐related permanent neonatal diabetes: Achieving insulin discontinuation and sulfonylurea reduction
Quick Look
Synchronous Presentation of Chronic Myelomonocytic Leukemia and Multiple Myeloma in a Treatment-Naïve Patient
Quick Look
Change in Effectiveness and Safety Parameters After Initiation of SGLT2 Inhibitors for Post-Transplant Diabetes Mellitus: A Real-World Observational Study
Quick Look
Type 1 diabetes‐specific distress among adults with type 1 diabetes in Japan
Quick Look
Efficacy and safety of GLP-1RA on cardio-metabolic outcomes in overweight or obese Chinese adults: a systematic review and meta-analysis
Quick Look
Implementing SGLT2 Inhibitor Therapy in Line with the New NICE Guidelines for Type 2 Diabetes Management
Quick Look
Data‐driven cluster analysis of adults with prediabetes: Findings from the Japan diabetes prevention study
Quick Look
A Phase 1/2, Open-Label, Single-Dose, Multicenter Study to Evaluate the Pharmacokinetics and Safety of Human Plasma-Derived Protein C Concentrate in Japanese Patients with Severe Congenital Protein C Deficiency (SCPCD)
Quick Look
Clonal Hematopoiesis and Type 2 Diabetes: A Narrative Review
Quick Look
Association of Sodium‐Glucose Cotransporter 2 Inhibitors Treatment With Contrast‐Induced Acute Kidney Injury in Older Adults With T2D and CKD: A Propensity Matched Analysis